Xoma reported $2.52M in EBITDA for its fiscal quarter ending in June of 2024.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Agenus USD -10.11M 19.02M Mar/2025
Agios Pharmaceuticals USD -120.31M 4.82M Dec/2025
Ardelyx USD -29.77M 35.79M Mar/2026
aTyr Pharma USD -54K 25.9M Mar/2026
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Celldex Therapeutics USD -83.58M 2.76M Mar/2026
Curis USD -12.3M 231K Sep/2023
Eli Lilly USD 12.14B 4.26B Dec/2025
Incyte USD 367.97M 46.53M Mar/2026
MacroGenics USD -30.2M 52.15M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Novartis USD 5.41B 431M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Prothena USD 25.98M 65.51M Mar/2026
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024